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ABSTRACT
Context: The development of in vitro methods is important in drug discovery process due to the restriction of animal use in the pharmacological 
screening process.
Objective: The objective of the review was to understand the in vitro pharmacological screening methods for anti-inflammatory agents.
Methods: The present review details various in vitro methods available for the screening of activity of therapeutic agents against inflammation. 
Results: Inhibition and measurement of nitric oxide production, mast cell degranulation, leukocyte adhesion assay, platelet-neutrophil adhesion 
assay, lipopolysaccharide-induced response assay, N-formyl-methionyl-leucyl-phenylalanine-induced O2 generation by polymorphonuclear cells, and 
cyclooxygenase assays are discussed in this review.
Conclusions: These methods help to understand the real mechanism of inflammation and mediators involved in this process and help to identify new 
compounds possessing the anti-inflammatory activity.
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INTRODUCTION
Inflammation is the process in which a series of reactions occur as a 
part of body’s defense mechanism against various endogenous and 
exogenous stimuli. According to its length, inflammation is classified as 
acute and chronic. Healing, a process which is not completed without 
inflammation, is an immune response of the body; to remove foreign 
body from the body, it may be living organism, chemical or physical 
stimuli. The main symptoms of inflammation are pain, swelling, redness, 
heat, and immobility [1]. The major components of inflammation are 
categorized as vascular and cellular changes. Vascular changes involve 
increased blood flow, momentary vasoconstriction of blood vessels, and 
vasodilation of arterioles and venules; increased permeability leads 
to release of chemical mediators, swelling, and increased viscosity. 
Cellular changes involve migration of leukocyte from circulation to 
the degradation of bacteria. These changes could be monitored for the 
investigation of anti-inflammatory activity of a compound [2]. The major 
signs of the inflammation are pain, swelling, and fever. Large varieties 
of anti-inflammatory drugs are available in the market. However, none 
of these drugs are free from side effects. The development of less 
gastric irritation producing drugs is important. In addition to in vivo 
method, some standard primary assays are available to investigate the 
anti-inflammatory activity in drug discovery process. The development 
of in vitro methods is important in drug discovery process due to the 
restriction of animal use in the pharmacological screening process. 
In vitro assays are simple and not complex like in vivo methods. Most of 
these methods mimic in vivo response and are now widely used for the 
monitoring and development of new agents against inflammation [3].
INHIBITION OF NITRIC OXIDE (NO) PRODUCTION IN MOUSE 
MACROPHAGES
NO acts as important mediators in inflammatory process. During 
inflammation, large amount of NO is produced. Hence, inhibition of NO 
production property of a compound is one of the important criteria 
in the pharmacological screening of anti-inflammatory activity [4]. 
A standard anti-inflammatory steroid drug like hydrocortisone is taken 
as positive control in this type of assay. The test compound is dissolved 
in dimethyl sulfoxide and added to cell culture. Here, macrophages are 
obtained by intraperitoneal injection of thioglycollate broth to mice. 
After 4–5 days of injection, peritoneal macrophages are harvested and 
proceeded according to Ding’s procedure. Incubation of cells is then 
carried out in 96-well plates with IFN gamma with or without the agent 
under test [5].
The presence of nitrite in a medium is used as an indicator of NO 
production [5]. In the presence of oxygen, NO is converted to nitrite, 
which could be measured using the Griess reaction. The Griess reaction 
is the easiest and simplest colorimetric assay for the determination 
of nitrite [6]. Here, Griess reagent is placed into both the culture 
media containing test substance and without the test substance. The 
plates are incubated for 10 min at 37°C and are read at 570 nm with 
a spectrophotometer. The nitrite concentrations are estimated using a 
calibration curve of sodium nitrite [7].
MAST CELL DEGRANULATION
During the inflammation and allergy, the mast cells are degranulated. 
The degree of this degranulation is a significant criterion in the 
pharmacological screening process of therapeutic agents against 
inflammation [8]. The mast cell degranulation models are widely 
utilized for this study. In addition to degranulation, histamine and 
beta-hexosaminidase are also released, which stimulate the metabolic 
process of arachidonic acid. The measurement of such substances 
is also helpful in the pharmacological screening process for new 
anti-inflammatory agents. There are several methods employed to 
detect degranulation of mast cells and release of mediators. They include 
enzyme-linked immunosorbent assays (ELISAs) or colorimetric assays. 
Colorimetric assay to measure the inflammatory mediators is rapid and 
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sensitive. Another reported method is based on the particle analysis of 
granules in RBL-2H3 cells [9]. Fluorometric assay of histamine [10] and 
flow cytometric Annexin-V binding assay [11] are also available for this 
purpose. The percentage release of inflammatory mediator is the index 
of anti-inflammatory activity.
ADHESION ASSAY
Adhesion of leukocytes is an important cellular stage during the 
inflammation process [12]. Adhesion assay involves the estimation 
of vascular proteins vascular cell adhesion molecule 1, intercellular 
adhesion molecule 1, and E-selectin in primary cells derived from 
human umbilical vein endothelial cells and human microvascular 
endothelial cell line [13]. Human dermal microvascular endothelial 
cells are the most suitable to predict in vivo situations in the best 
manner [14]. In the adhesion assay, tumor necrosis factor (TNF)-alpha 
stimulated cell lines are incubated with test drug [15]. The procedure 
involves labeling of neutrophil with appropriate fluorescent materials 
and allowing adhering. Finally, the measurement of fluorescence is 
carried out at 485 nm in an ELISA reader [14].
Platelet-neutrophil adhesion assay
In this method, neutrophils are mixed with thrombin-activated 
platelets, which are previously incubated with drugs for 10 min [16]. If 
the test drug inhibits the adhesion of neutrophils, it indicates an anti-
inflammatory activity of the tested drug. A control is also carried out 
along with the test sample [14].
Neutrophil adhesion to hypoxia-stimulated porcine aorta
Here, the porcine aorta is stimulated by placing them into phosphate-
buffered saline gassed with N2 and placed between steel plates having 
holes and Teflon blocks. The drug under test and neutrophils are added 
on the side of the plates and incubated for 90 min. The measure of the 
adhesion of neutrophils in the presence of drug is carried out. A control 
with the absence of drug is also carried out [14].
LIPOPOLYSACCHARIDE (LPS)-INDUCED RESPONSE ASSAY
Expression of inducible NO synthase (iNOS) protein, NO production, 
TNF-alpha expression, and p38 MAP Kinase (MAPK) by LPS in 
mouse macrophages can be utilized for screening anti-inflammatory 
activity [17]. When cell lines are treated with LPS, it induces the 
production of iNOS proteins, NO, TNF-alpha expression, and MAPK 
protein expression; these can be measured by western blot method 
[18]. This should be performed with and without the presence of 
the test drug. In the presence of existing anti-inflammatory drugs, 
a reduction in the production of these substances will be noted. The 
degree of inhibition could be compared with standard drugs.
N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 
(FMLP)-INDUCED O2 GENERATION BY POLYMORPHONUCLEAR 
CELLS (PMNS)
Many compounds are generated during inflammatory process. FMLP 
induces reactive oxygen species (ROS). ROS is one of the substances 
whose concentration is increased in leukocytes, PMNs, monocytes, and 
vascular endothelial cells during inflammation [19]. Generation of such 
a substance may contribute to various degenerative diseases such as 
arthritis. Estimation of such a substance is one of the important criteria 
for the pharmacological screening of anti-inflammatory agent. The 
degree of the ability to decrease the production of ROS reflects the anti-
inflammatory activities of new compounds.
CYCLOOXYGENASE (COX) ASSAYS
The COX enzymes convert arachidonic acid to prostaglandins [20]. COX 
has two forms, COX-1 and COX-2 [21]. Here, COX-1 is constitutive, which 
is important in physiological functions, whereas COX-2 is inducible and 
involved in pathological function [22]. In the inflammatory process, 
this enzyme has an important role. Hence, the estimation of the end 
product such as prostaglandin concentration will be helpful in the 
pharmacological screening of anti-inflammatory agents. The various 
in vitro methods are employed for this purpose.
COX-1 assay
In this assay, the sample solution was mixed with L-adrenaline-D-
hydrogen tartrate and hematin. Then, the incubation of the mixture 
is carried out with COX-1. Then, the arachidonic acid is added and 
incubated for 20 min at 37°C. Addition of formic acid to the mixture 
stops the incubation. Using enzyme immunoassay, measure the 
concentration of prostaglandin 2 [23].
COX-2 assay
The basis of this assay is that N,N,N’,N’-tetramethyl-p-phenylenediamine 
(TMPD) gets oxidized when the reduction of prostaglandin-G2 to 
prostaglandin-H2 occurs [24]. The oxidation velocity of TMPD is 
measured spectrophotometrically. The sample is introduced to the 
mixture of sodium phosphate buffer, gelatin, hematin, and purified 
COX-2. This mixture is pre-incubated with arachidonic acid before 
the addition of TMPD. The percentage inhibition is determined by 
measuring the absorbance at 610 nm [25].
CONCLUSIONS
From the literature review, it can be seen that several in vitro methods 
are developed for the pharmacological screening of anti-inflammatory 
activity. Many of the methods reflect in vivo performance. These 
methods help to understand the real mechanism of inflammation and to 
identify new compounds possessing the anti-inflammatory activity. It 
is very difficult to develop single in vitro method for anti-inflammatory 
activity. Even in future, the mentioned method will accelerate the anti-
inflammatory drug development process.
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